We are live on ! Find out more
VIE

Viela Bio, Inc. Common Stock
VIE

Delisted

VIE was delisted on the 12th of March, 2021.

Back to rankings

60 hedge funds and large institutions have $725M invested in Viela Bio, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 33 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 15

8% less funds holding

Funds holding: 65 → 60 (-5)

33% less capital invested

Capital invested by funds: $1.09B → $725M (-$360M)

50% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 10

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
60
Holders Change
-5
Holders Change %
-7.69%
% of All Funds
1.21%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
33
Reduced
15
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$19.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$13.5M
3
JP Morgan Chase
JP Morgan Chase
New York
+$6.98M
4
American Century Companies
American Century Companies
Missouri
+$5.47M
5
Millennium Management
Millennium Management
New York
+$4.63M

Top Sellers

Rank Fund Capital Flow
1
HA
HHLR Advisors
Cayman Islands
-$12M
2
Goldman Sachs
Goldman Sachs
New York
-$8M
3
Viking Global Investors
Viking Global Investors
Connecticut
-$7.29M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$5.54M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$2.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
51
Ameritas Investment Partners
Nebraska
$50K – – –
TRCT
52
Tower Research Capital (TRC)
New York
$44K -$93.4K -2,641 -63%
AA
53
AlphaCentric Advisors
Puerto Rico
$42K +$53.1K +1,500 New
Citigroup
54
Citigroup
New York
$36K -$214K -6,060 -82%
Bank of Montreal
55
Bank of Montreal
Ontario, Canada
$30K -$20.9K -592 -37%
Pacer Advisors
56
Pacer Advisors
Pennsylvania
$16K +$19.5K +552 New
MAM
57
Meeder Asset Management
Ohio
$9K +$11.9K +335 New
Millennium Management
58
Millennium Management
New York
$4.04K +$4.63M +130,871 +1,020%
SFS
59
Sowell Financial Services
Arkansas
$2K +$2.41K +68 New
Point72 Asset Management
60
Point72 Asset Management
Connecticut
– -$5.54M -127,983 Closed
First Trust Advisors
61
First Trust Advisors
Illinois
– -$2.79M -64,497 Closed
PCM
62
Pinz Capital Management
New York
– -$1.35M -31,150 Closed
AC
63
Athanor Capital
New York
– -$320K -7,377 Closed
Prudential Financial
64
Prudential Financial
New Jersey
– -$269K -6,206 Closed
AAMU
65
Amundi Asset Management US
Massachusetts
– -$221K -5,100 Closed
CSS
66
Cubist Systematic Strategies
Connecticut
– -$53K -1,222 Closed
Osaic Holdings
67
Osaic Holdings
Arizona
– -$2K -50 Closed
Royal Bank of Canada
68
Royal Bank of Canada
Ontario, Canada
– +$177 +5 +125%
1 2
3

VIE Hedge Fund Activity: Q3 2020 in Review

60 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Viela Bio, Inc. Common Stock (VIE) for Q3 2020, worth a combined $725M — down 33% from $1.09B a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of VIE and 5 opened new positions — a net loss of 5 holders — while 15 trimmed existing stakes and 33 added.

The largest buyer was State Street, adding an estimated $19.3M. The largest seller was HHLR Advisors, cutting an estimated $12M.

  • 60 institutional investors held Viela Bio, Inc. Common Stock (VIE) as of Q3 2020, down from 65 in Q2 2020.
  • Funds reported $725M of Viela Bio, Inc. Common Stock stock for Q3 2020, down 33% quarter-over-quarter.
  • 5 funds opened new Viela Bio, Inc. Common Stock positions in Q3 2020 and 10 closed out, a net change of -5 holders.
  • The largest Viela Bio, Inc. Common Stock buyer in Q3 2020 was State Street, an estimated $19.3M added.
  • The largest Viela Bio, Inc. Common Stock seller in Q3 2020 was HHLR Advisors, an estimated $12M sold.

Based on aggregated 13F filings for Q3 2020.